Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Transition Metal Complex. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102417523A reveals novel nitrogen heterocyclic ligands enabling high-selectivity asymmetric hydrogenation of hindered ketones for cost-effective pharmaceutical manufacturing.
Patent CN1791607A details novel chiral ligands enabling high enantioselectivity. Discover cost-effective manufacturing and scalable supply solutions for pharmaceutical intermediates.
Advanced patent CN106146543A enables efficient synthesis of chiral alpha-amino tertiary borates. High enantioselectivity and scalable process for pharmaceutical intermediates.
Patent CN1468212A introduces a safe, cost-effective asymmetric cyanation method using alkali metal cyanides and chiral titanium catalysts for high-purity pharmaceutical intermediates.
Patent CN108276261B details a green aqueous oxidation method for 2-bromofluorenone, offering high purity and cost reduction in electronic chemical manufacturing.
Patent CN113087742B details a novel synthesis for phosphine chiral center compounds using stable oxides. Enables cost-effective production of high-purity catalysts.